Idarucizumab for Dabigatran Reversal — Full Cohort Analysis Pollack, CV et al. “Idarucizumab for Dabigatran Reversal — Full Cohort Analysis.” DOI: 10.1056/NEJMoa1707278 By Cassandra Pardini, PharmD Publish Date July 11, 2017